Cardiovascular Drugs
The best tips and advice from our vast library of articles, videos, and business tools
Browse Related Topics
Free Industry Resources
Newly Added Articles
- RuBiRu: Run, bike, run to fight tumors: Support...
- WIC is updating its menu: Nutrition program for...
- Tax tips for the unemployed
- reassessment blues
- Sanford to expand orthopedic, sports programs
- Jim Carvin, political guru, dies
- Clark County Quarterly Report - A 'pretty good'...
Search Results
1-20 of 560 related articles
"Insufficient use of diuretics in combination antihypertensive therapy is a main cause of poor blood pressure (BP) control...
unaggregatedarticle
Reliant Pharmaceuticals Inc., which markets four cardiovascular products in the U.S., is trying again to complete an initial...
unaggregatedarticle
Washington Editor GAITHERSBURG, Md. - The FDA's Cardiovascular and Renal Drugs Advisory Committee voted unanimously to recommend approval...
unaggregatedarticle
According to recent research from Bombay, India, "High blood pressure is one of the most important risk factors,...
unaggregatedarticle
West Coast Editor Talk about making the pulse race: Privately held Vitae Pharmaceuticals Inc., with its renin inhibitor...
unaggregatedarticle
Staff Writer It seems Texas Biotechnology Corp. is sticking to its guns. Just two months after reporting plans...
unaggregatedarticle
Staff Writer Spinning off subsidiaries left and right, Endovasc Ltd. Inc. this week attributed the moves to a...
unaggregatedarticle
Washington Editor The FDA approved a wider label for Aceon (perindopril erbumine), acardiovascular drug marketed in part by...
unaggregatedarticle
Washington Editor Synaptic Pharmaceutical Corp. said it granted Procter & Gamble Pharmaceuticals Inc. an exclusive patent license for...
unaggregatedarticle
Advanced Viral Research Corp., of Yonkers, N.Y., completed a $3 million institutional financing, funds the firm says enable...
unaggregatedarticle
Staff Writer ISTA Pharmaceuticals Inc. said Friday a new drug application was submitted to the FDA by its...
unaggregatedarticle
Washington Editor ISTA Pharmaceuticals Inc. expects to enter the $1.1 billion U.S. glaucoma market sometime early next year...
unaggregatedarticle
Senior Staff Writer After dropping its initial public offering range, DOV Pharmaceutical Inc. priced its public offering at...
unaggregatedarticle
Staff Writer Just days after Alexion Pharmaceuticals Inc. said it completed enrollment in a pivotal trial of its...
unaggregatedarticle
Nov. 1--A nine-year national study measuring the effects of lowering blood-pressure levels will have a decided local influence....
unaggregatedarticle
A nine-year national study measuring the effects of lowering blood-pressure levels will have a decided local influence. Wake...
unaggregatedarticle
The following information was released by the American College of Cardiology (ACC): Cardiac complications around the time of...
unaggregatedarticle
Senior Staff Writer Adding to its portfolio of eye disease therapeutics, Ista Pharmaceuticals licensed a calcium channel blocker...
unaggregatedarticle
o Alteon Inc., of Parsippany, N.J., said one of its collaborators at the Baker Heart Research Institute in...
unaggregatedarticle
Washington Editor Poor Celacade data sank shares of Vasogen Inc., though the companys top executive pointed to a...
unaggregatedarticle
How to Turn Your Business Dream into a Successful Reality
Napa Valley business owners tell Sumer Morenz of D&B Digital TV how they turned passion into bottom-line success.
Franchise Finder
Find your perfect franchise
Choose your location and industry and we'll show you the most relevant franchises.
Sponsored Links
Site Map | Contact Us | FAQs | About Us | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy
Media Kit
Copyright © 1999 - 2009 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.
Get In-Depth Company Information from Hoover's | Buy a D&B Credit Report | What is in Your Company's D&B Credit Report?
Online Business Database | Online Business Information | Sales and Marketing Solutions | Business Mailing Lists | Company Profiles
Online Business Database | Online Business Information | Sales and Marketing Solutions | Business Mailing Lists | Company Profiles
Information and opinions on AllBusiness.com solely represent the thoughts and opinions of the authors and are not endorsed by, or reflect the beliefs of,
AllBusiness.com, its parent company D&B, and its affiliates.
AllBusiness.com, its parent company D&B, and its affiliates.
